Cerity Partners LLC Acquires New Holdings in Amdocs Limited (NASDAQ:DOX)

Cerity Partners LLC bought a new position in shares of Amdocs Limited (NASDAQ:DOXFree Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 4,475 shares of the technology company’s stock, valued at approximately $393,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Operose Advisors LLC increased its stake in shares of Amdocs by 148.0% in the third quarter. Operose Advisors LLC now owns 310 shares of the technology company’s stock valued at $26,000 after buying an additional 185 shares during the period. VisionPoint Advisory Group LLC increased its position in Amdocs by 77.7% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 503 shares of the technology company’s stock valued at $42,000 after acquiring an additional 220 shares during the period. Allworth Financial LP raised its stake in shares of Amdocs by 16,840.0% during the third quarter. Allworth Financial LP now owns 847 shares of the technology company’s stock valued at $72,000 after acquiring an additional 842 shares during the last quarter. Quent Capital LLC lifted its holdings in shares of Amdocs by 27.3% during the fourth quarter. Quent Capital LLC now owns 1,148 shares of the technology company’s stock worth $101,000 after purchasing an additional 246 shares during the period. Finally, Blue Trust Inc. grew its stake in shares of Amdocs by 17.9% in the fourth quarter. Blue Trust Inc. now owns 1,418 shares of the technology company’s stock worth $119,000 after purchasing an additional 215 shares during the last quarter. Institutional investors own 92.02% of the company’s stock.

Analyst Ratings Changes

DOX has been the subject of several analyst reports. Citigroup raised their target price on Amdocs from $96.00 to $104.00 and gave the stock a “buy” rating in a research report on Wednesday, January 17th. Barclays raised their price objective on Amdocs from $105.00 to $115.00 and gave the stock an “overweight” rating in a research report on Thursday, February 8th. Finally, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a report on Friday, March 15th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $108.60.

Get Our Latest Research Report on DOX

Amdocs Stock Down 0.8 %

Shares of NASDAQ:DOX opened at $84.98 on Friday. The business’s 50-day moving average is $89.62 and its 200-day moving average is $87.32. Amdocs Limited has a 1 year low of $78.38 and a 1 year high of $99.75. The company has a market capitalization of $9.99 billion, a price-to-earnings ratio of 18.20, a P/E/G ratio of 1.41 and a beta of 0.69. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.29 and a quick ratio of 1.29.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings results on Tuesday, February 6th. The technology company reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.16. The firm had revenue of $1.25 billion for the quarter, compared to analyst estimates of $1.24 billion. Amdocs had a return on equity of 17.79% and a net margin of 11.30%. The company’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.33 earnings per share. Equities research analysts predict that Amdocs Limited will post 5.87 earnings per share for the current year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, April 26th. Shareholders of record on Friday, March 29th were paid a $0.479 dividend. This is an increase from Amdocs’s previous quarterly dividend of $0.44. This represents a $1.92 annualized dividend and a yield of 2.25%. The ex-dividend date was Wednesday, March 27th. Amdocs’s payout ratio is 41.11%.

Amdocs Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Featured Stories

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.